Randomized trial of paroxetine in end-stage COPD
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Although the underlying pathology is initially confined to the lungs, the associated emotional responses to chronic obstructive pulmonary disease (COPD) contribute greatly to the resulting morbidity. The objective of this study was to examine the effect of an antidepressant drug on disease-specific quality of life in patients with end-stage COPD who present significant depressive symptoms. Methods: We conducted a 12-week, randomized double- blind placebo-controlled trial of Paroxetine in which quality of life measured by the Chronic Respiratory Questionnaire (CRQ), an evaluative COPD-specific quality-oflife questionnaire, was the primary outcome. Results: 23 patients were randomized and 15 completed the trial (8 on Paroxetine; 7 on placebo). In the per-protocol analysis, we observed statistically and clinically significant improvements favoring the active treatment in 2 of the 4 domains of the CRQ: emotional function (adjusted mean difference: 1.1; 95% confidence interval [CI]: 0.0 - 2.2) and mastery (difference: 1.1; CI: 0.4 - 1.8). Dyspnea and fatigue improved, but to an extent that did not reach statistical significance. In the intention-to-treat analysis, none of the differences in CRQ scores was significant. Paroxetine was not associated to any worsening of respiratory symptoms. Conclusions: The results of this small randomized trial indicated that patients with end-stage COPD may benefit from antidepressant drug therapy when significant depressive symptoms are present. This study underlined the difficulties in conducting experimental studies in frail and elderly patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721 · cited 1×
“Primary outcome: The change in score in the “emotional function” domain of the Chronic Respiratory Questionnaire (CRQ) at 12-week followup represented the primary outcome of this trial [ 14 ].”
MethodBarriers to Participation in Randomised Controlled Trials
Ross, S., Grant, A., Counsell, C., Gillespie, W., Russell, I., & Prescott, R. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00141-9 · Cited by 907
Borson, S., McDonald, G. J., Gayle, T., Deffebach, M., Lakshminarayan, S., & VanTuinen, C. (1992) · Psychosomatics · doi:10.1016/s0033-3182(92)71995-1 · Cited by 277
Lacasse, Y., Rousseau, L., & Maltais, F. (2001) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200103000-00004 · Cited by 184
Self-citation
Cited by
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2042st · Cited by 1,844
Puhan, M. A., Frey, M., Büchi, S., & Schünemann, H. J. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-46 · Cited by 586
McKenzie, D. K., & Frith, P. A. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05213.x · Cited by 369
Anxiety and depression-Important psychological comorbidities of COPD.
Pumar, M., Gray, C. R., Walsh, J., Yang, I. A., Rolls, T., & Ward, D. L. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.09.28 · Cited by 272
Anxiety and depression in end-stage COPD
Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008) · European Respiratory Journal · doi:10.1183/09031936.00125707 · Cited by 269
Self-citationMarciniuk, D. D., Goodridge, D., Hernandez, P., Rocker, G., Balter, M., Bailey, P., Ford, G., Bourbeau, J., O’Donnell, D. E., Maltais, F., et al. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/745047 · Cited by 264
Self-citationPharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227
Pollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59
“Cochrane Database of Systematic Reviews Allocation We deemed three studies that adequately described their randomisation methods as at low risk of bias for random sequence generation (Borson 1992; He 2016; Lacasse 2004).”
BackgroundMethodResultInfluentialUsmani, Z. A., Carson, K. V., Cheng, J. N., Esterman, A. J., & Smith, B. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008483.pub2 · Cited by 57
Developing an intervention for depressed, chronically medically ill elders: A model from COPD
Alexopoulos, G. S., Raue, P. J., Sirey, J. A., & Arean, P. A. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1925 · Cited by 48
Metadata
- Authors
- Lacasse, Y., Beaudoin, L., Rousseau, L., & Maltais, F.
- Venue
- Monaldi Archives for Chest Disease
- Publisher
- PAGEPress Publications
- Published
- 2004-09-30
- Volume
- 61
- Issue
- 3
- Pages
- 140-7
- ISSN
- 1120-0391 (ISSN-L)
- 2465-1028
- 1122-0643
- OpenAlex
- W1555678263
- Cited by
- 102
- References
- 6
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.